ScienceMed®

Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-analysis

Gastroenterologia
Imagem de arquivo, ilustrativa — não é do estudo. Células HeLa em cultura, em microscopia de fluorescência. NIH · domínio público · Wikimedia Commons

MetanáliseNível 1 · Evidência consolidadaAnnals of surgical oncology16 jun 20263 citações

Salvar

Resumo original em inglês

O que aconteceu

After curative-intent pancreatectomy for pancreatic ductal adenocarcinoma (PDAC), disease recurrence occurs almost invariably. Evidence guiding treatment of recurrence remains limited and may differ across single-site recurrence patterns.

Scopus, MEDLINE, and the Cochrane Library were systematically searched for observational studies of adults with recurrent PDAC reporting liver-only, lung-only, or locoregional recurrence and post-recurrence treatments. Hazard ratio (HR) meta-analyses were performed to compare survival outcomes between treatment strategies for each recurrence location with additional descriptive survival summaries.

O que encontraram

The inclusion criteria were met by 22 studies, with 17 included in the quantitative synthesis. Pattern-specific analyses favored selected local therapies. For liver-only recurrence, local therapy was associated with longer overall survival than chemotherapy alone (HR 0.26, 95% confidence interval [CI] 0.14-0.49), mainly due to surgical resection (HR 0.18; 95% CI 0.11-0.31). Ablation did not reach statistical significance. In lung-only recurrence, surgical resection was associated with longer survival than conventional management (HR 0.35; 95% CI 0.26-0.48). For locoregional recurrence, resection was associated with longer survival (HR 0.52; 95% CI 0.38-0.72). Stereotactic body radiotherapy outcomes from three small series were summarized descriptively.

Por que isso importa

Pancreatic ductal adenocarcinoma recurrence outcomes differ significantly by recurrence pattern. Across liver-only, lung-only, and locoregional recurrence, selected patients undergoing local therapy had longer survival than those managed conventionally. Although current observational data do not confirm broad efficacy for specific methods, these results support recurrence pattern-specific prospective evaluation to define optimal site-tailored strategies.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-analysis

Aya Maekawa, Giampaolo Perri, Danhui Heo, Giulia Cemin, Anouk Janine van Bodegraven, Clarissa De Nardi, Agata Grochowska, Umberto Cillo, Giovanni Marchegiani

Descritores MeSH

  • Carcinoma, Pancreatic Ductal
  • Lung Neoplasms
  • Neoplasm Recurrence, Local
  • Pancreatectomy
  • Pancreatic Neoplasms
  • Liver Neoplasms
  • Humans
  • Survival Rate
  • Combined Modality Therapy
  • Prognosis

Veja também